CRP and COVID-19: Several clinical or biological markers, including ferritin, C-reactive protein, and pro-inflammatory interleukin-1 and interleukin-6, have currently been identified to help predict the course of COVID-19 and, therefore, can potentially help to guide IGAM usage [32].